Boc-L-aspartic acid β-9-fluorenylmethyl ester

Boc-L-aspartic acid β-9-fluorenylmethyl ester is a protected L-aspartic acid derivative designed for peptide synthesis workflows, combining an N-terminal Boc protecting group with a side-chain β-9-fluorenylmethyl (Fm) ester that masks the carboxylate functionality. This protection pattern supports controlled peptide assembly while reducing undesired side reactions associated with aspartate side-chain reactivity. The Fm ester is commonly leveraged in orthogonally protected building blocks when selective deprotection strategies are needed during stepwise synthesis and segment coupling.

1. Solid-Phase Peptide Synthesis

Boc-L-aspartic acid β-9-fluorenylmethyl ester is used as an aspartate building block in solid-phase peptide synthesis where the side-chain carboxylate must remain protected throughout chain elongation. Peptide chemists rely on the Boc/Fm protection scheme to maintain compatibility with standard stepwise coupling conditions while minimizing side reactions that can occur with free aspartate side-chain acids. This reagent is frequently selected for preparing peptides that require aspartate residues in defined sequences, including longer sequences where side-chain protection stability during repeated deprotection/coupling cycles is a practical concern.

2. Orthogonally Protected Aspartate Segments

Boc-L-aspartic acid β-9-fluorenylmethyl ester supports segment condensation and complex peptide assembly by providing a protected aspartate side chain that can be unmasked at an appropriate stage of synthesis. In custom peptide manufacturing and library workflows, the ability to manage N-terminus and β-carboxyl protection independently helps streamline purification and reduce the risk of cross-reactivity between functional groups present in neighboring residues or coupling partners. The Fm ester side-chain protection is particularly valuable when synthetic plans require selective deprotection timing to generate a reactive aspartate functionality only when the peptide backbone and other protecting groups are already configured for the next transformation.

3. Aspartate-Containing Peptide Libraries

Boc-L-aspartic acid β-9-fluorenylmethyl ester is applied in the preparation of peptide libraries and SAR-focused peptide variants where consistent incorporation of aspartate residues is essential for comparing sequence-dependent properties. Researchers in peptide chemistry and medicinal chemistry use this protected building block to ensure that each library member carries the aspartate side chain in the correct protected state during synthesis, enabling reliable downstream deprotection to yield the native β-carboxyl group in the final peptide. The reagent's protection pattern makes it a practical choice for iterative parallel synthesis workflows that demand reproducible handling of acidic side chains and minimized batch-to-batch variability in protected intermediates.

4. Pharmaceutical Intermediate Development

Boc-L-aspartic acid β-9-fluorenylmethyl ester is also used as a defined, protected aspartate intermediate in the upstream development of peptide-based pharmaceutical intermediates, including protected fragments that later feed into larger coupling sequences. Process chemists and peptide development teams value the clear functional group masking provided by Boc on the amino terminus and the Fm ester on the β-carboxyl, because it supports controlled reactivity during intermediate isolation and subsequent assembly steps. This makes the reagent relevant to workflows where aspartate-containing intermediates must be manufactured with predictable protection behavior before conversion into final peptide structures.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency